Profiel
Charles Hugh-Jones is the Global Chief Medical Officer at Fresenius Medical Care AG, starting in 2026.
Formerly, Dr. Hugh-Jones was Chief Executive Officer at Volastra Therapeutics, Inc., Chief Medical Officer at Allergan UC from 2018 to 2020, and worked at Addleshaw Booth & Co. from 2004 to 2007.
Actieve functies van Charles Hugh-Jones
| Bedrijven | Functie | Begin |
|---|---|---|
| FRESENIUS MEDICAL CARE AG | Hoofd Techniek/Wetenschap/O&O | 01-01-2026 |
Eerdere bekende functies van Charles Hugh-Jones
| Bedrijven | Functie | Einde |
|---|---|---|
Volastra Therapeutics, Inc.
Volastra Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in discovery and development of oncology therapeutics | Algemeen Directeur | 27-05-2025 |
| ALLERGAN PLC | Hoofd Techniek/Wetenschap/O&O | 08-05-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Fresenius Medical Care AG
Fresenius Medical Care AG Medical/Nursing ServicesHealth Services Manufactures and supplies renal and dialysis products | Health Services |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Volastra Therapeutics, Inc.
Volastra Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in discovery and development of oncology therapeutics | Health Technology |
















